Detection of Viral Citrullinated Peptide Antibodies Directed Against EBV or VCP: In Early Rheumatoid Arthritis Patients of Indian Origin
2010

Detection of Viral Citrullinated Peptide Antibodies in Early Rheumatoid Arthritis Patients

Sample size: 90 publication Evidence: moderate

Author Information

Author(s): Deo Sudha S, Shetty Rashmi R, Mistry Kejal J, Chogle Arun R

Primary Institution: Sir. H.N. Medical Research Society

Hypothesis

The study aims to analyze the frequency of anti-viral citrullinated peptide antibodies in sera from patients with early rheumatoid arthritis.

Conclusion

The presence of VCP antibody signifies a good marker for early rheumatoid arthritis.

Supporting Evidence

  • VCP IgM antibody was significantly increased in RA patients compared to healthy controls.
  • VCP antibody presence indicates a potential viral role in early rheumatoid arthritis.
  • Significant differences in antibody levels were observed between early RA patients and healthy controls.

Takeaway

This study found that patients with early rheumatoid arthritis have antibodies that react to a virus, which might help in diagnosing the disease.

Methodology

The study used in-house ELISA to detect antibodies in sera from 25 early rheumatoid arthritis patients, 40 disease controls, and 25 healthy controls.

Limitations

The sensitivity of the assays was low, and the study was limited to a specific population.

Participant Demographics

25 early rheumatoid arthritis patients aged 32 to 62 years, with a mean age of 47 years, and a male to female ratio of 2:23.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.4103/0974-2727.72158

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication